Hib vaccine conjugate - Sanofi
Alternative Names: ActHIB; DF-098; Haemophilus influenzae type b conjugate vaccine - SanofiLatest Information Update: 31 Mar 2022
Price :
$50 *
At a glance
- Originator Sanofi
- Class Conjugate vaccines; Haemophilus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Haemophilus infections
Most Recent Events
- 31 Oct 2018 Sanofi and Daiichi Sankyo agree to terminate Hib vaccine conjugate in Japan for Haemophilus infections
- 02 Aug 2010 sanofi pasteur-Daiichi Sankyo Vaccine Co. agrees to terminate its shareholders agreement on October 31, 2010
- 30 Jul 2010 sanofi pasteur reaches an agreement to acquire sanofi pasteur-Daiichi Sankyo Vaccine